Point72 Hong Kong’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Point72 Hong Kong’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9	Closed	–	–	1678
2020 Q2	$0	Buy	+9	New	+$408	﹤0.01%	1532

Other funds holding VIE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Point72 Hong Kong's VIE Position: Q3 2020 in Review

Point72 Hong Kong sold out of Viela Bio, Inc. Common Stock (VIE) in Q3 2020, closing a stake of 9 shares.

Point72 Hong Kong first reported a position in VIE in Q2 2020 and held it in 1 quarter. The position peaked at $0 in Q2 2020. 60 funds tracked by Wall St. Rank hold VIE as of Q3 2020.

Point72 Hong Kong reported no remaining Viela Bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Point72 Hong Kong sold 9 Viela Bio, Inc. Common Stock shares in Q3 2020.
Point72 Hong Kong first reported a position in Viela Bio, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
Point72 Hong Kong's Viela Bio, Inc. Common Stock position peaked at $0 in Q2 2020.
60 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q3 2020.

Based on Point72 Hong Kong's 13F filing for Q3 2020, filed 16 Nov 2020.